Óscar Fernández

8.6k total citations · 1 hit paper
199 papers, 4.9k citations indexed

About

Óscar Fernández is a scholar working on Pathology and Forensic Medicine, Neurology and Oncology. According to data from OpenAlex, Óscar Fernández has authored 199 papers receiving a total of 4.9k indexed citations (citations by other indexed papers that have themselves been cited), including 134 papers in Pathology and Forensic Medicine, 54 papers in Neurology and 52 papers in Oncology. Recurrent topics in Óscar Fernández's work include Multiple Sclerosis Research Studies (127 papers), Peripheral Neuropathies and Disorders (46 papers) and Polyomavirus and related diseases (26 papers). Óscar Fernández is often cited by papers focused on Multiple Sclerosis Research Studies (127 papers), Peripheral Neuropathies and Disorders (46 papers) and Polyomavirus and related diseases (26 papers). Óscar Fernández collaborates with scholars based in Spain, United States and Italy. Óscar Fernández's co-authors include Per Soelberg Sørensen, O. R. Hommes, Laura Leyva, Massimo Filippi, Frederik Barkhof, Luca Durelli, Gilles Edan, Marco Rovaris, Fuencisla Matesanz and Pierrette Seeldrayers and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Óscar Fernández

191 papers receiving 4.8k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Effect of early interferon treatment on conversion to definite multiple sclerosis: a randomised study

2001 757 citations Óscar Fernández et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Óscar Fernández Spain	35	3.1k	1.2k	1.1k	960	956	199	4.9k
Gavin Giovannoni United Kingdom	10	3.5k 1.1×	1.2k 1.0×	1.1k 0.9×	878 0.9×	1.4k 1.5×	20	4.6k
Nils Koch‐Henriksen Denmark	37	3.7k 1.2×	959 0.8×	973 0.9×	1.0k 1.0×	909 1.0×	93	4.8k
Douglas Jeffery United States	26	2.7k 0.9×	1.2k 1.0×	560 0.5×	761 0.8×	768 0.8×	84	3.7k
Neil P. Robertson United Kingdom	38	2.9k 0.9×	1.6k 1.3×	1.2k 1.1×	822 0.9×	537 0.6×	151	4.9k
Stephen Lake United States	28	2.1k 0.7×	772 0.6×	964 0.9×	705 0.7×	790 0.8×	66	5.6k
John Rose United States	35	3.7k 1.2×	1.8k 1.5×	1.6k 1.4×	1.2k 1.2×	986 1.0×	144	5.9k
Aaron Miller United States	31	2.9k 0.9×	1.2k 1.0×	604 0.5×	952 1.0×	676 0.7×	119	4.0k
John R. Corboy United States	32	2.3k 0.7×	1.1k 1.0×	730 0.7×	628 0.7×	527 0.6×	110	3.9k
Omar Khan United States	33	2.1k 0.7×	917 0.8×	715 0.6×	599 0.6×	950 1.0×	87	3.9k
Guillermo Izquierdo Spain	29	2.5k 0.8×	911 0.8×	803 0.7×	548 0.6×	698 0.7×	131	4.1k

Countries citing papers authored by Óscar Fernández

Since Specialization

Citations

This map shows the geographic impact of Óscar Fernández's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Óscar Fernández with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Óscar Fernández more than expected).

Fields of papers citing papers by Óscar Fernández

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Óscar Fernández. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Óscar Fernández. The network helps show where Óscar Fernández may publish in the future.

Co-authorship network of co-authors of Óscar Fernández

This figure shows the co-authorship network connecting the top 25 collaborators of Óscar Fernández. A scholar is included among the top collaborators of Óscar Fernández based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Óscar Fernández. Óscar Fernández is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Fernández, Óscar, Lucienne Costa‐Frossard, José María Prieto González, et al.. (2024). Practical tool to identify Spasticity-Plus Syndrome amongst patients with multiple sclerosis. Algorithm development based on a conjoint analysis. Frontiers in Neurology. 15. 1371644–1371644.

Fernández, Óscar, et al.. (2023). Manufacturing acceleration of free-form micro-optical arrays (FMOAs) with CAD algorithms. 32–32.

Patti, Francesco, et al.. (2022). A real‐world evidence study of nabiximols in multiple sclerosis patients with resistant spasticity: Analysis in relation to the newly described ‘spasticity‐plus syndrome’. European Journal of Neurology. 29(9). 2744–2753. 18 indexed citations

Meca-Lallana, José, Celia Oreja‐Guevara, David G. Muñoz, et al.. (2021). Four-year safety and effectiveness data from patients with multiple sclerosis treated with fingolimod: The Spanish GILENYA registry. PLoS ONE. 16(10). e0258437–e0258437. 5 indexed citations

Pérez‐Miralles, Francisco, Daniel Prefasi, Antonio Garcı́a-Merino, et al.. (2021). Brain region volumes and their relationship with disability progression and cognitive function in primary progressive multiple sclerosis. Brain and Behavior. 11(4). e02044–e02044. 5 indexed citations

Callegaro, Dagoberto, Marco Aurélio Lana–Peixoto, Óscar Fernández, et al.. (2021). Evaluation of diagnosis and treatment practices of Brazilian neurologists among patients with multiple sclerosis. Arquivos de Neuro-Psiquiatria. 79(7). 598–606. 1 indexed citations

Fernández, Óscar, Laura Leyva, Fernando Rodrı́guez de Fonseca, et al.. (2020). Activation of Macrophages by Lysophosphatidic Acid through the Lysophosphatidic Acid Receptor 1 as a Novel Mechanism in Multiple Sclerosis Pathogenesis. Molecular Neurobiology. 58(2). 470–482. 22 indexed citations

Steingo, Brian, Yaser Al Malik, Ann Bass, et al.. (2020). Long-term efficacy and safety of alemtuzumab in patients with RRMS: 12-year follow-up of CAMMS223. Journal of Neurology. 267(11). 3343–3353. 41 indexed citations

Martín‐Montañez, Elisa, Federica Boraldi, Silvia Claros, et al.. (2020). Neuronal Metabolism and Neuroprotection: Neuroprotective Effect of Fingolimod on Menadione-Induced Mitochondrial Damage. Cells. 10(1). 34–34. 9 indexed citations

10.

Oliver‐Martos, Begoña, Celia Oreja‐Guevara, Ana Alonso, et al.. (2020). Skin Phototype Could Be a Risk Factor for Multiple Sclerosis. Journal of Clinical Medicine. 9(8). 2384–2384.

11.

Fernández, Óscar, Guillermo Izquierdo, Eduardo Agüera, et al.. (2020). Comparison of first-line and second-line use of fingolimod in relapsing MS: The open-label EARLIMS study. Multiple Sclerosis Journal - Experimental Translational and Clinical. 6(3). 2455377326–2455377326. 7 indexed citations

12.

Fernández, Óscar, Maurizio Delvecchio, Gilles Edan, et al.. (2018). Survey of diagnostic and treatment practices for multiple sclerosis (MS) in Europe. Part 2: Progressive MS, paediatric MS, pregnancy and general management. European Journal of Neurology. 25(5). 739–746. 7 indexed citations

13.

Fernández, Óscar, et al.. (2017). Treatment satisfaction with injectable disease-modifying therapies in patients with relapsing-remitting multiple sclerosis (the STICK study). PLoS ONE. 12(10). e0185766–e0185766. 23 indexed citations

14.

Benabdellah, Karim, Carolina Melero‐Jerez, Begoña Oliver‐Martos, et al.. (2016). Gene therapy with mesenchymal stem cells expressing IFN‐ß ameliorates neuroinflammation in experimental models of multiple sclerosis. British Journal of Pharmacology. 174(3). 238–253. 38 indexed citations

15.

Caillier, Stacy J., Xavier Montalbán, Pablo Villoslada, et al.. (2008). Genome-Wide Pharmacogenomic Analysis of the Response to Interferon Beta Therapy in Multiple Sclerosis. Archives of Neurology. 65(3). 337–44. 118 indexed citations

16.

Alves‐Leon, Soniza Vieira, et al.. (2006). Ethnicity-dependent association of HLA DRB1-DQA1-DQB1 alleles in Brazilian multiple sclerosis patients. Acta Neurologica Scandinavica. 115(5). 306–311. 46 indexed citations

17.

Chejne, Farid, et al.. (2005). Propuesta metodológica para el diseño de las aspas de turbinas de viento de eje horizontal.. LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas). 37–45. 2 indexed citations

18.

Fernández, Óscar, et al.. (2000). Actitudes hipocondríacas en mujeres antes y después de participar en pruebas complementarias de detección de cáncer de mama. Psiquis: Revista de psiquiatría, psicología médica y psicosomática. 21(5). 20–28. 2 indexed citations

19.

Fernández, Óscar, Rosemary Wangensteen, Antonio Osuna, & Félix Vargas. (2000). Renal Vascular Reactivity to P<sub>2</sub>-Purinoceptor Activation in Spontaneously Hypertensive Rats. Pharmacology. 60(1). 47–50. 14 indexed citations

20.

Fernández, Óscar & Victoria Fernández. (1997). Esclerosis múltiple: una enfermedad relativamente frecuente en España. Dialnet (Universidad de la Rioja). 2(1). 43–57. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact